Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
NCT03380390
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Rosacea
Interventions
DRUG:
Oxymetazoline HCL 1.0% Cream
DEVICE:
Energy-Based Therapy
Sponsor
Aclaris Therapeutics, Inc.